MedTrace Logo

The Effect of High Single Dose of Dexamethasone in Prevention of Post-operative Acute Kidney Injury in Cardiac Surgeries Requiring Cardiopulmonary Bypass

NCT06783634 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-01-20

No results posted yet for this study

Summary

The aim of the current study is to assess the effect of intra operative single high dose dexamethasone (1 mg/kg) in decreasing the incidence of post-operative acute kidney injury after cardiac surgeries with cardiopulmonary bypass

Conditions

  • Acute Kidney Injury After Adult Cardiac Surgery

Interventions

DRUG

Dexamethasone

Group 2 (dexamethasone group) single intra venous high dose of dexamethasone 1mg/kg with maximum dose of 100 mg.

DRUG

Placebo

Group 1 (Control group) will receive normal saline as a placebo.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Nourhan E Abdellatif, MBBCH · Anesthesia resident Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2025-03-25
Completion
2025-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06783634 on ClinicalTrials.gov